Lfng - LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase Gene
Species: Mus musculus
Summary
Enables O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity. Involved in lymphocyte differentiation; negative regulation of Notch signaling pathway involved in somitogenesis; and somitogenesis. Acts upstream of or within several processes, including compartment pattern specification; positive regulation of Notch signaling pathway; and regulation of somitogenesis. Predicted to be located in Golgi membrane. Is expressed in several structures, including alimentary system; embryo ectoderm; genitourinary system; inner ear; and paraxial mesenchyme. Human ortholog(s) of this gene implicated in spondylocostal dysostosis. Orthologous to human LFNG (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase). [provided by Alliance of Genome Resources, Apr 2022]
Lfng Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_008494.3 | NP_032520.1 | beta-1,3-N-acetylglucosaminyltransferase lunatic fringe precursor |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
IDA
IDA: Inferred from direct assay
|
16221665 | MGI |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
beta-1,3-N-acetylglucosaminyltransferase lunatic fringe |
|